HEIDELBERG, Germany, Dec. 25,
2024 /PRNewswire/ -- European Wellness
Biomedical Group (EWBG) has launched a new research initiative
focused on Klotho, a protein with transformative potential
in longevity medicine. Led by Professor Dr. Mike Chan, this project will explore
Klotho's role in combating age-related diseases and its ability to
regenerate critical organs, including the brain,
kidneys, and heart.
Klotho, identified in 1997, is emerging as a key protein
in longevity and regenerative medicine. It plays a pivotal role in
regulating oxidative stress, mineral metabolism, and inflammation.
The research will investigate how boosting Klotho levels could help
address chronic conditions like neurodegenerative diseases,
kidney failure, and heart disease, ultimately
improving healthspan and extending lifespan.
"Klotho represents the next frontier in longevity
medicine," said Professor Mike
Chan, Chief Scientist at EWBG. "Our research aims to
understand how Klotho affects aging and how we can use it to treat
chronic diseases that have long been associated with aging."
Research Focus Areas
The new initiative will focus on three primary research
areas:
- Neurological health: Investigating Klotho's
neuroprotective effects and its potential to slow cognitive decline
in diseases like Alzheimer's and Parkinson's.
- Kidney function: Examining Klotho's role in regulating
mineral metabolism and its regenerative potential in treating
chronic kidney disease (CKD).
- Cardiovascular health: Studying Klotho's influence on
vascular function and its ability to prevent vascular
calcification, a key contributor to heart disease.
This research builds on existing collaborations at EWBG,
where leading scientists focus on advancing Klotho-based therapies
for regenerative health.
Klotho: A Potential Breakthrough in Longevity
Medicine
Klotho is gaining attention for its ability to regenerate
tissues and reverse damage caused by age-related diseases. Unlike
NAD+, which primarily enhances cellular metabolism and
energy production, Klotho offers a broader range of therapeutic
applications, including tissue regeneration, cognitive function
improvement, and cardiovascular health.
As we age, Klotho levels naturally decline, leading to
conditions such as cognitive decline, heart disease, and kidney
failure. Research suggests that restoring Klotho levels can reverse
the effects of oxidative stress, inflammation, and cellular
senescence, offering new treatment possibilities for a range of
age-related diseases.
Professor Mike Chan: Leading
the Charge in Klotho Research
Professor Mike Chan, a
leading expert in stem cell therapy and longevity
medicine, is spearheading this groundbreaking initiative at
EWBG. His extensive experience in bio-regenerative medicine
positions him as a key figure in exploring Klotho's potential to
revolutionize the treatment of age-related diseases. Through
FCTI, a subsidiary of EWBG, Professor Chan and his team are
developing therapies that combine stem cell technology and
Klotho proteins to stimulate tissue regeneration in the
brain, kidneys, and heart.
"By harnessing Klotho's regenerative properties, we hope to
address chronic conditions that were previously untreatable," said
Professor Chan. "Our ultimate goal is to improve quality of
life and provide lasting solutions for those affected by
aging-related diseases."
The Future of Klotho in Longevity Medicine
The future of Klotho-based therapies looks promising,
with Professor Mike Chan and
EWBG at the forefront of this innovative field. As more
research is conducted, Klotho is expected to play a pivotal role in
advancing longevity medicine, offering a new approach to
treating aging and chronic diseases. The potential applications of
Klotho are vast, from neurodegenerative disease treatment to
kidney regeneration and cardiovascular health.
With strong research partnerships, significant funding, and
ongoing clinical trials, Klotho is poised to become a cornerstone
of longevity medicine, transforming how we approach aging
and disease. Professor Mike
Chan's leadership ensures that this promising protein
will soon offer new hope to those seeking longer, healthier
lives.
Photo -
https://mma.prnewswire.com/media/2587407/Prof_Dr_Mike_Chan_talks_growing_importance_Klotho_anti_aging_medicine.jpg
Logo
- https://mma.prnewswire.com/media/2362609/EW_COLOR_Logo.jpg
View original
content:https://www.prnewswire.co.uk/news-releases/european-wellness-biomedical-group-announces-new-klotho-research-initiative-led-by-prof-mike-chan-302338980.html
